TIM3+ Tregs exhibited higher suppressive capacities relative to TIM3- Tregs towards T helper (Th) 1 and Th17 cells, with TIM3 expression being correlated to worse prognosis in lung cancer (Gao et al., 2012; Gautron et al., 2014). Here, HAVCR2 is linked to lung carcinoma.